195rar

To prove that SYK was directly talking to FLT3, scientists needed to break the physical connection between them. They focused on a specific part of the SYK protein called the .

Because this specific interaction is so vital for the cancer to progress, it identified a new potential "weak spot" that future drugs could target to treat AML more effectively. 195rar

In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation To prove that SYK was directly talking to

SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia In a study published in , scientists investigated

This tiny change—the mutation—acted like changing the shape of a key so it no longer fits a lock. What the Story Revealed

In scientific research, "195RAR" refers to a specific genetic mutation used to study how certain proteins interact within the body, particularly in the context of cancer development.